Navigation Links
Study shows major pain research funding decline at NIH
Date:12/11/2008

GLENVIEW, IL, Dec. 11, 2008 Federal funding for pain research is declining sharply, more than 9 percent a year since 2003, according to a new study published in The Journal of Pain. Pain research, as a result, now accounts for only 0.6 percent of all grants awarded by the National Institutes of Health (NIH), despite the high prevalence of chronic pain in the U.S.

"This startling finding shows the government's meager investment in pain research is seriously out of proportion with the widespread chronic pain incidence in our society, which is estimated at one in four Americans and accounts for more than 20 percent of all physician office visits," said Charles E. Inturrisi, president of the American Pain Society and professor of pharmacology at Weill Cornell Medical College, New York. "And this disparity is not attributable to years of budget cuts at NIH because the Journal of Pain study clearly shows pain research has a higher percentage decline than the overall NIH budget. So the drop in agency funding has not affected all research areas equally."

University of Utah researchers led by David H. Bradshaw, PhD of the university's pain research center, analyzed data about NIH grant awards from 2003 through 2007 for pain and compared pain research funding with dollars allocated for nausea and dyspnea, a breathing disorder. A previous study authored by Bradshaw, also published in The Journal of Pain in 2005, found that less than one percent of all NIH funding in 2003 was for research having a primary emphasis on pain. The current study shows that five years later pain research is still a low priority at NIH.

Noting that overall budget pressures in Washington have led to an unprecedented recession in funding for biomedical research, the authors said: "With decreased funding for research and continuing needs for resources to support national security and military efforts, major natural disasters and uncertain e
'/>"/>

Contact: Chuck Weber
cpweber@weberpr.com
847-705-1802
American Pain Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Womens magazines downplay emotional health risks of cosmetic surgery: UBC study
2. Study Asks: Are Physicians Overusing an Invasive Cardiac Treatment?
3. Study Questions Value of Anti-Meth Campaign
4. U.S. Department of Education Funded Study Demonstrates, WordWorld, a PBS KIDS(R) Television Series Works as Critical Early Literacy Tool
5. Success of anti-meth ads questioned by study
6. Study first to show that RNA interference can facilitate vaccine development
7. Study Suggests Sugar May Be Addictive
8. UC San Diego scientists developing brain imaging methods for studying natural human behavior
9. Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
10. Study finds selenium, vitamin E do not prevent prostate cancer
11. Study Finds Doctors Use of E-Prescribing Systems Linked to Formulary Data Can Boost Drug Cost Savings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015 The American Telemedicine Association (ATA) ... reports which identify gaps in coverage and reimbursement, and ... the State Telemedicine Gaps Reports last September, many state ... and regulations impact healthcare delivery in their state,” said ... state actions across the nation, ATA reevaluated the indicators ...
(Date:5/4/2015)... METTLER TOLEDO has announced an upcoming ... in a GXP Regulated Laboratory ", featuring independent ... will be presented on May 27, 2015 at ... a critical component of pharmaceutical product quality and ... recent years an increasing number of inspections have ...
(Date:5/4/2015)... 04, 2015 EY today announced that ... a finalist for the EY Entrepreneur Of The Year® ... awards program recognizes entrepreneurs who demonstrate excellence and extraordinary ... personal commitment to their businesses and communities. Mr. ... of independent judges. Award winners will be announced ...
(Date:5/4/2015)... Ticket Down is a reputable source for ... in Columbia, South Carolina. Fans of Paul McCartney ... There” tour which originally kicked off in 2013. The most ... and the legendary performer recently announced that he would be ... on June 21st, in Charlottesville, VA at John Paul Jones ...
(Date:5/4/2015)... 04, 2015 San Diego Fertility ... at their brand new, 13,700 square foot facility scheduled ... building will not only provide fertility treatment and services ... offer community and educational events to a number of ... located next door to their current Carmel Valley/Del Mar ...
Breaking Medicine News(10 mins):Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 3Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2Health News:EY announces Kit Check CEO and Co-founder Kevin MacDonald as an EY Entrepreneur Of The Year® 2015 Award finalist in the Greater Washington Region 2Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3
... ... Leading Physicians of the World has now made their elite group of physicians accessible online. ... put themselves in the hands of an expert physician for their next visit., , ... New York, NY (PRWEB) March 23, ...
... , President & CEO of Medicaid Health Plans of America (MHPA), the leading trade association solely focused on representing Medicaid health plans, issued the following statement after the House ... ... ... ...
... National Alliance on Mental Illness ( NAMI ) has launched StrengthofUs.org , a new online community where young adults living with mental ... ... , , ... ...
... Lindt Chocolate , the world,s leading producer of premium chocolate, today announces the 2010 Lindt Unsung Heroes of Autism . ... affected by autism in their families, homes and communities.   , ... ... ...
... , March 23 Connectyx Technologies Holdings Group, ...  has appointed Dr. James R. Taylor to its ... healthcare and pharmaceutical field. He has written several publications; in ... elite institutions, such as the University of Florida , ...
... ... , ... ... ATLANTA , March 23 Radiotherapy Centers of Georgia (RCOG), a division of RC Cancer Centers announced today ...
Cached Medicine News:Health News:Findatopdoc.com Uses Cutting Edge Technology in Bringing the Leading Physicians of the World Directly to Your Computer For Consumers to Find a Top Doctor 2Health News:MHPA Statement on Health Reform Legislation 2Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 2Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 3Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 4Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 5Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 6Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 7Health News:Lindt USA Announces 'Lindt Unsung Heroes of Autism' 2Health News:Lindt USA Announces 'Lindt Unsung Heroes of Autism' 3Health News:Lindt USA Announces 'Lindt Unsung Heroes of Autism' 4Health News:Lindt USA Announces 'Lindt Unsung Heroes of Autism' 5Health News:Lindt USA Announces 'Lindt Unsung Heroes of Autism' 6Health News:Connectyx Technologies Holdings Group, Inc. Appoints Dr. James R. Taylor to Its Board of Advisors 2Health News:Connectyx Technologies Holdings Group, Inc. Appoints Dr. James R. Taylor to Its Board of Advisors 3Health News:Connectyx Technologies Holdings Group, Inc. Appoints Dr. James R. Taylor to Its Board of Advisors 4Health News:Connectyx Technologies Holdings Group, Inc. Appoints Dr. James R. Taylor to Its Board of Advisors 5Health News:Prostate Cancer Treatment Database Hits Milestone of 12,500 2Health News:Prostate Cancer Treatment Database Hits Milestone of 12,500 3Health News:Prostate Cancer Treatment Database Hits Milestone of 12,500 4Health News:Prostate Cancer Treatment Database Hits Milestone of 12,500 5
(Date:5/4/2015)... 2015 PharmaEngine, Inc. (TWO:4162) today announced ... MACK ) with its sublicensing partner, Baxter ... that Baxter has submitted a marketing authorization application ... MM-398 (irinotecan liposome injection), also known as "nal-IRI," ... who have been previously treated with gemcitabine-based therapy. ...
(Date:5/4/2015)... 2015  Oncobiologics, Inc., a biotherapeutics company focused ... has completed the construction of its GMP commercial ... Cranbury, New Jersey . ... designed to utilize multiple technologies that enable rapid ... the use of the latest single-use technologies, the ...
(Date:5/4/2015)... , May 4, 2015   HeartWare International, Inc ... invasive, miniaturized circulatory support technologies that are revolutionizing the treatment ... Doug Godshall , is scheduled to present at the ... Las Vegas on Thursday, May 14, ... The live webcast of the Company,s presentation at the conference ...
Breaking Medicine Technology:PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 3HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2
... I clinical trial in healthy subjects- Study aims ... new vaccine candidate- Initial results expected in Q4 ... by PATHVIENNA, April 7 Intercell AG (VSE: ... trial with the company,s vaccine candidate IC47 to ...
... Glycotex, Inc. today announced the completion of a scheduled ... effect of investigational GLYC-101 gel on complete wound closure ... dioxide laser skin resurfacing on the lower eyelid area.The ... study. The comparison of each active arm to placebo ...
Cached Medicine Technology:Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine 2Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine 3Glycotex' Investigational Compound GLYC-101 Achieves Accelerated Wound Closure Based on Interim Analysis 2Glycotex' Investigational Compound GLYC-101 Achieves Accelerated Wound Closure Based on Interim Analysis 3
... Wampole Laboratories offers a comprehensive line ... for serum and urine in convenient one-step ... offers 2 testing options. Clearview Easy HCG ... a convenient stick format. Clearview HCG ...
... line of pregnancy tests including rapid membrane ... one-step stick and cassette formats. The Clearview ... HCG is a 25 mIU urine test ... HCG II provides 25mIU sensitivity for urine ...
For the quantitative determination of Glycohemoglobin (HbA1) in blood by,cation exchange resin. The test is to be used to monitor long-term glucose,control in diabetes mellitus....
Rapid turn-around time, results in less than 4 hours...
Medicine Products: